Cargando…

The ABA/LANCL Hormone/Receptor System in the Control of Glycemia, of Cardiomyocyte Energy Metabolism, and in Neuroprotection: A New Ally in the Treatment of Diabetes Mellitus?

Abscisic acid (ABA), long known as a plant stress hormone, is present and functionally active in organisms other than those pertaining to the land plant kingdom, including cyanobacteria, fungi, algae, protozoan parasites, lower Metazoa, and mammals. The ancient, cross-kingdom role of this stress hor...

Descripción completa

Detalles Bibliográficos
Autores principales: Spinelli, Sonia, Magnone, Mirko, Guida, Lucrezia, Sturla, Laura, Zocchi, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863406/
https://www.ncbi.nlm.nih.gov/pubmed/36674711
http://dx.doi.org/10.3390/ijms24021199
_version_ 1784875326298390528
author Spinelli, Sonia
Magnone, Mirko
Guida, Lucrezia
Sturla, Laura
Zocchi, Elena
author_facet Spinelli, Sonia
Magnone, Mirko
Guida, Lucrezia
Sturla, Laura
Zocchi, Elena
author_sort Spinelli, Sonia
collection PubMed
description Abscisic acid (ABA), long known as a plant stress hormone, is present and functionally active in organisms other than those pertaining to the land plant kingdom, including cyanobacteria, fungi, algae, protozoan parasites, lower Metazoa, and mammals. The ancient, cross-kingdom role of this stress hormone allows ABA and its signaling pathway to control cell responses to environmental stimuli in diverse organisms such as marine sponges, higher plants, and humans. Recent advances in our knowledge about the physiological role of ABA and of its mammalian receptors in the control of energy metabolism and mitochondrial function in myocytes, adipocytes, and neuronal cells allow us to foresee therapeutic applications for ABA in the fields of pre-diabetes, diabetes, and cardio- and neuro-protection. Vegetal extracts titrated in their ABA content have shown both efficacy and tolerability in preliminary clinical studies. As the prevalence of glucose intolerance, diabetes, and cardiovascular and neurodegenerative diseases is steadily increasing in both industrialized and rapidly developing countries, new and cost-efficient therapeutics to combat these ailments are much needed to ensure disease-free aging for the current and future working generations.
format Online
Article
Text
id pubmed-9863406
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98634062023-01-22 The ABA/LANCL Hormone/Receptor System in the Control of Glycemia, of Cardiomyocyte Energy Metabolism, and in Neuroprotection: A New Ally in the Treatment of Diabetes Mellitus? Spinelli, Sonia Magnone, Mirko Guida, Lucrezia Sturla, Laura Zocchi, Elena Int J Mol Sci Review Abscisic acid (ABA), long known as a plant stress hormone, is present and functionally active in organisms other than those pertaining to the land plant kingdom, including cyanobacteria, fungi, algae, protozoan parasites, lower Metazoa, and mammals. The ancient, cross-kingdom role of this stress hormone allows ABA and its signaling pathway to control cell responses to environmental stimuli in diverse organisms such as marine sponges, higher plants, and humans. Recent advances in our knowledge about the physiological role of ABA and of its mammalian receptors in the control of energy metabolism and mitochondrial function in myocytes, adipocytes, and neuronal cells allow us to foresee therapeutic applications for ABA in the fields of pre-diabetes, diabetes, and cardio- and neuro-protection. Vegetal extracts titrated in their ABA content have shown both efficacy and tolerability in preliminary clinical studies. As the prevalence of glucose intolerance, diabetes, and cardiovascular and neurodegenerative diseases is steadily increasing in both industrialized and rapidly developing countries, new and cost-efficient therapeutics to combat these ailments are much needed to ensure disease-free aging for the current and future working generations. MDPI 2023-01-07 /pmc/articles/PMC9863406/ /pubmed/36674711 http://dx.doi.org/10.3390/ijms24021199 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Spinelli, Sonia
Magnone, Mirko
Guida, Lucrezia
Sturla, Laura
Zocchi, Elena
The ABA/LANCL Hormone/Receptor System in the Control of Glycemia, of Cardiomyocyte Energy Metabolism, and in Neuroprotection: A New Ally in the Treatment of Diabetes Mellitus?
title The ABA/LANCL Hormone/Receptor System in the Control of Glycemia, of Cardiomyocyte Energy Metabolism, and in Neuroprotection: A New Ally in the Treatment of Diabetes Mellitus?
title_full The ABA/LANCL Hormone/Receptor System in the Control of Glycemia, of Cardiomyocyte Energy Metabolism, and in Neuroprotection: A New Ally in the Treatment of Diabetes Mellitus?
title_fullStr The ABA/LANCL Hormone/Receptor System in the Control of Glycemia, of Cardiomyocyte Energy Metabolism, and in Neuroprotection: A New Ally in the Treatment of Diabetes Mellitus?
title_full_unstemmed The ABA/LANCL Hormone/Receptor System in the Control of Glycemia, of Cardiomyocyte Energy Metabolism, and in Neuroprotection: A New Ally in the Treatment of Diabetes Mellitus?
title_short The ABA/LANCL Hormone/Receptor System in the Control of Glycemia, of Cardiomyocyte Energy Metabolism, and in Neuroprotection: A New Ally in the Treatment of Diabetes Mellitus?
title_sort aba/lancl hormone/receptor system in the control of glycemia, of cardiomyocyte energy metabolism, and in neuroprotection: a new ally in the treatment of diabetes mellitus?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863406/
https://www.ncbi.nlm.nih.gov/pubmed/36674711
http://dx.doi.org/10.3390/ijms24021199
work_keys_str_mv AT spinellisonia theabalanclhormonereceptorsysteminthecontrolofglycemiaofcardiomyocyteenergymetabolismandinneuroprotectionanewallyinthetreatmentofdiabetesmellitus
AT magnonemirko theabalanclhormonereceptorsysteminthecontrolofglycemiaofcardiomyocyteenergymetabolismandinneuroprotectionanewallyinthetreatmentofdiabetesmellitus
AT guidalucrezia theabalanclhormonereceptorsysteminthecontrolofglycemiaofcardiomyocyteenergymetabolismandinneuroprotectionanewallyinthetreatmentofdiabetesmellitus
AT sturlalaura theabalanclhormonereceptorsysteminthecontrolofglycemiaofcardiomyocyteenergymetabolismandinneuroprotectionanewallyinthetreatmentofdiabetesmellitus
AT zocchielena theabalanclhormonereceptorsysteminthecontrolofglycemiaofcardiomyocyteenergymetabolismandinneuroprotectionanewallyinthetreatmentofdiabetesmellitus
AT spinellisonia abalanclhormonereceptorsysteminthecontrolofglycemiaofcardiomyocyteenergymetabolismandinneuroprotectionanewallyinthetreatmentofdiabetesmellitus
AT magnonemirko abalanclhormonereceptorsysteminthecontrolofglycemiaofcardiomyocyteenergymetabolismandinneuroprotectionanewallyinthetreatmentofdiabetesmellitus
AT guidalucrezia abalanclhormonereceptorsysteminthecontrolofglycemiaofcardiomyocyteenergymetabolismandinneuroprotectionanewallyinthetreatmentofdiabetesmellitus
AT sturlalaura abalanclhormonereceptorsysteminthecontrolofglycemiaofcardiomyocyteenergymetabolismandinneuroprotectionanewallyinthetreatmentofdiabetesmellitus
AT zocchielena abalanclhormonereceptorsysteminthecontrolofglycemiaofcardiomyocyteenergymetabolismandinneuroprotectionanewallyinthetreatmentofdiabetesmellitus